Implementing Pharmacogenetic Testing in Gastrointestinal Cancers

Clinical trial NCT04736472 · COMPLETED

Trial details

NCT number: NCT04736472
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Gastrointestinal Cancer

Start date: 2021-03-26
Primary completion: 2023-12-19
Enrollment: 552

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.